Nplate® Pregnancy Exposure Registry
NCT02090088 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2015-01-06
Summary
US study to estimate the prevalence at birth of major birth defects (ie, those that cause significant functional or cosmetic impairment, require surgery, or are life-limiting) in children born to mothers who have received Nplate® therapy at any time during the pregnancy.
Conditions
- Birth Defect
- Spontaneous Abortions
- Low Birth Weight
Interventions
- DRUG
-
Not applicable- observational study
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
More Related Trials
-
Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
NCT00116272 ·Status: COMPLETED
-
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
NCT05016440 ·Status: WITHDRAWN ·Phase: NA
-
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health
NCT02509988 ·Status: COMPLETED ·Phase: NA
-
Abatacept Pregnancy Exposure Registry
NCT01087125 ·Status: COMPLETED
-
Metformin and Esomeprazole in Preterm Pre-eclampsia
NCT06359015 ·Status: TERMINATED ·Phase: PHASE4
-
Non Invasive Prenatal Test of Rare Genetic Diseases: Application to Rare Intellectual Disabilities
NCT03688594 ·Status: UNKNOWN ·Phase: NA
-
Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
NCT01351428 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
NCT01566630 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
NCT02920593 ·Status: UNKNOWN ·Phase: PHASE4
-
Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
NCT06122220 ·Status: RECRUITING ·Phase: NA
-
sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia
NCT05228002 ·Status: COMPLETED ·Phase: NA
-
Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia
NCT06314555 ·Status: COMPLETED
-
Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
NCT01095939 ·Status: COMPLETED ·Phase: PHASE3
-
Genotyping of Human Platelet Alloantigens : Non-invasive Prenatal Diagnosis
NCT02899598 ·Status: WITHDRAWN ·Phase: NA
-
PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention
NCT02346162 ·Status: COMPLETED ·Phase: NA
-
Evolocumab Pregnancy Exposure Registry
NCT02957604 ·Status: TERMINATED
-
Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
NCT06004674 ·Status: RECRUITING ·Phase: PHASE2
-
Improving Aspirin Prescription Rates in Outpatient Clinic
NCT06694233 ·Status: TERMINATED
-
Preeclampsia Intervention Netherlands
NCT06452498 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 ·Status: COMPLETED
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
NCT05739123 ·Status: RECRUITING
-
Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)
NCT05096728 ·Status: COMPLETED
-
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
NCT03008616 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED